Some of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been limited published data and little experience in Australia of their safety or efficacy. However, the Editorial Executive Committee believes that comments made in good faith at an early stage may still be of value. As a result of fuller experience, initial comments may need to be modified. The Committee is prepared to do this. Before new drugs are prescribed, the Committee believes it is important that full information is obtained either from the manufacturer's approved product information, a drug information centre or some other appropriate source.
Gonal-F (Serono)
ampoules containing 75 IU or 150 IU as powder for reconstitution
Indication: follicular development
Follitropin alpha is a genetically engineered follicle stimulating hormone. A similar product, follitropin beta is already on the market, but has slightly different indications. Follitropin alpha has
been approved for controlled ovarian hyper stimulation in women `undergoing assisted reproductive technologies' and for the treatment of an ovulatory infertility in women who have a contraindication
or have failed to respond to clomiphene.
